AU2023900376A0 - Biomarkers and uses thereof - Google Patents

Biomarkers and uses thereof

Info

Publication number
AU2023900376A0
AU2023900376A0 AU2023900376A AU2023900376A AU2023900376A0 AU 2023900376 A0 AU2023900376 A0 AU 2023900376A0 AU 2023900376 A AU2023900376 A AU 2023900376A AU 2023900376 A AU2023900376 A AU 2023900376A AU 2023900376 A0 AU2023900376 A0 AU 2023900376A0
Authority
AU
Australia
Prior art keywords
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023900376A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Percheron Therapeutics Ltd
Original Assignee
Antisense Therapeutics Ltd
Filing date
Publication date
Application filed by Antisense Therapeutics Ltd filed Critical Antisense Therapeutics Ltd
Publication of AU2023900376A0 publication Critical patent/AU2023900376A0/en
Priority to PCT/AU2023/050777 priority Critical patent/WO2024036373A1/en
Pending legal-status Critical Current

Links

AU2023900376A 2022-08-16 2023-02-16 Biomarkers and uses thereof Pending AU2023900376A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2023/050777 WO2024036373A1 (en) 2022-08-16 2023-08-16 Biomarkers and uses thereof in diagnosis and treatment of neurological post acute sequelae of covid 19 (npasc)

Publications (1)

Publication Number Publication Date
AU2023900376A0 true AU2023900376A0 (en) 2023-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP4096712A4 (en) Deoptimized sars-cov-2 and methods and uses thereof
EP4141538A4 (en) Softbox and chuck assembly therefor
EP4146343A4 (en) Sars-cov-2 immunoassay and materials therefor
EP4121031A4 (en) 3-diarylmethylenes and uses thereof
EP4132974A4 (en) Anti-cd98 antibodies and uses thereof
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
AU2023900376A0 (en) Biomarkers and uses thereof
EP4169950A4 (en) Anti-lilrb1 antibody and uses thereof
AU2023902061A0 (en) Biomarkers and uses therefor
AU2022901154A0 (en) Biomarkers and uses therefor
AU2022900109A0 (en) Biomarkers and uses therefor
EP4153313A4 (en) Anti-sars-cov-2 antibodies and uses thereof
GB202306925D0 (en) Biomarkers and uses thereof
AU2023901461A0 (en) AIPROPERTY and AIREALESTATE
AU2022900253A0 (en) Prognostic biomarkers and uses therefor
AU2023902115A0 (en) Compounds and Uses Therefor
AU2023902113A0 (en) Compounds and uses therefor
AU2023901760A0 (en) Compounds and uses therefor
AU2023901069A0 (en) Aptamers and uses therefor
AU2023901070A0 (en) Aptamers and uses therefor
AU2023901071A0 (en) Aptamers and uses therefor
AU2022900859A0 (en) Aptamers and uses therefor
AU2022900861A0 (en) Aptamers and uses therefor
AU2022900858A0 (en) Aptamers and uses therefor
IL304313A (en) Novel biomarkers and uses thereof